Search Within

Sergio Andres Giralt

  1. "Myeloma"
Formats
  1. Meeting Abstract (173)
  2. Journal Article (56)
  3. Research Letter (6)
  4. Correspondence (3)
Groups
  1. Bone Marrow Transplant (238)
  2. Center for Hematologic Malignancies (238)
  3. Department of Medicine (238)
  4. Hematologic Malignancies, Division of (238)
  5. Myeloma (238)
  6. Survivorship Research (223)

More Groups

People
  1. Hani Hassoun (205)
  2. Heather Landau (202)
  3. Alexander Lesokhin (185)
  4. David Chung (180)
  5. Sham Mailankody (161)
  6. Gunjan Shah (152)

More People

Years
  1. 2025 (9)
  2. 2024 (37)
  3. 2023 (36)
  4. 2022 (27)
  5. 2021 (15)
  6. 2020 (16)

More Years

Publications
  1. Blood (103)
  2. Clinical Lymphoma, Myeloma and Leukemia (41)
  3. Biology of Blood and Marrow Transplantation (24)
  4. Journal of Clinical Oncology (11)
  5. Leukemia and Lymphoma (10)
  6. Bone Marrow Transplantation (8)

More Publications

Publishers
  1. American Society of Hematology (109)
  2. Elsevier Inc. (71)
  3. Nature Publishing Group (19)
  4. American Society of Clinical Oncology (11)
  5. Taylor & Francis Group (10)
  6. Massachusetts Medical Society (4)

More Publishers

Results (238)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Patterns of disease relapse and progression in patients with multiple myeloma after first line therapy with autologous stem cell transplantation: Implications for patient monitoring after transplantation
    Meeting Abstract

    Zamarin, D.; Bhutani, M.; Chimento, D.; Giralt, S.; Lendvai, N.; Landau, H.; Lesokhin, A.; Chung, D.; Babu, D.; Hassoun, H.
    Blood (2011)

    Fulltext@MSK | Save
  • T-cell depleted allogeneic hematopoietic stem cell transplantation with busulfan, melphalan, and fludarabine conditioning followed by post transplantation donor lymphocyte infusions for patients with relapsed multiple myeloma and high-risk cytogenetics
    Meeting Abstract

    Koehne, G.; Landau, H.; Hassoun, H.; Lesokhin, A.; Lendvai, N.; Rosenzweig, M. A.; Heller, G.; Giralt, S.
    Blood (2011)

    Fulltext@MSK | Save
  • Cost analysis of using plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for autologous stem cell mobilization in multiple myeloma patients treated at Memorial Sloan-Kettering Cancer Center (MSKCC)
    Meeting Abstract

    Adel, N. G.; Duck, E.; Collum, K.; Mccullagh, E.; Reich, L.; Landau, H.; Giralt, S.; Hassoun, H.
    Blood (2011)

    Fulltext@MSK | Save
  • A pilot study of T-cell depleted allogeneic hematopoietic stem cell transplantation with busulfan, melphalan, and fludarabine conditioning followed by post transplantation donor lymphocyte infusions for patients with relapsed multiple myeloma and high-risk cytogenetics
    Meeting Abstract

    Koehne, G.; Landau, H.; Hassoun, H.; Lesokhin, A.; Lendvai, N.; Rosenzweig, M.; Chung, D. J.; Young, J. W.; Giralt, S.
    Biology of Blood and Marrow Transplantation (2011)

    Fulltext@MSK | Save
  • Phase III intergroup study of lenalidomide versus placebo maintenance therapy following single autologous stem cell transplant (ASCT) for multiple myeloma (MM): CALGB 100104
    Meeting Abstract

    McCarthy, P. L.; Owzar, K.; Anderson, K. C.; Hofmeister, C. C.; Hassoun, H.; Hurd, D. D.; Stadtmauer, E. A.; Giralt, S.; Hars, V.; Linker, C. A.; more...
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Effect of novel agents on stem cell (SC) mobilization and engraftment in patients with multiple myeloma (MM) at Memorial Sloan-Kettering Cancer Center
    Meeting Abstract

    Pozotrigo, M.; Adel, N. G.; LaRussa, V.; Chen, X.; Riedel, E.; Reich, L.; Landau, H.; Giralt, S.; Hassoun, H.
    Blood (2010)

    Fulltext@MSK | Save
  • Outcomes following salvage autologous stem cell transplant for multiple myeloma
    Meeting Abstract

    Fein, D. E.; Hassoun, H.; Comenzo, R. L.; Lesokhin, A.; Lendvai, N.; Chung, D.; Cohen, A.; Rosenzweig, M. A.; Chimento, D.; Jia, X.; more...
    Blood (2010)

    Fulltext@MSK | Save
  • High number of successful mobilizations associated with the use of plerixafor and colony stimulating factors in patients with multiple myeloma (MM) and lymphoma treated at Memorial Sloan-Kettering Cancer Center
    Meeting Abstract

    Adel, N. G.; Mathew, S.; Harnicar, S. J.; Mccullagh, E.; Landau, H.; Giralt, S.; Vanak, J.; Chimento, D.; Lucarelli, C.; Matasar, M. J.; more...
    Blood (2010)

    Fulltext@MSK | Save